Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Irani

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Urologic Oncology|February 14, 2013
Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinomaGéraldine Pignot, Pierre Colin, Marc Zerbib, et al.
World Journal of Urology|July 2, 2013
Risk stratification of metastatic recurrence in invasive upper urinary tract carcinoma after radical nephroureterectomy without lymphadenectomyPierre Colin, Tarek P Ghoneim, Laurent Nison, et al.
Annals of Surgical Oncology|July 31, 2012
Influence of positive surgical margin status after radical nephroureterectomy on upper urinary tract urothelial carcinoma survivalPierre Colin, Adil Ouzzane, David R Yates, et al.
European Urology|September 25, 2018
Mutational Profile of Aggressive, Localised Prostate Cancer from African Caribbean Men Versus European Ancestry MenLaurie Tonon, Gaëlle Fromont, Sandrine Boyault, et al.
Urologic Oncology|September 19, 2016
The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non-muscle-invasive bladder cancerJ Alfred Witjes, Guido Dalbagni, Robert J Karnes, et al.
BJU International|July 9, 2020
Urology surgical activity and COVID-19: risk assessment at the epidemic peak: a Parisian multicentre experienceAlexandre Ingels, Steeven Bibas, Maher Abdessater, et al.
European Urology Focus|January 19, 2021
Prognostic Impact of pT3 Subclassification in a Multicentre Cohort of Patients with Urothelial Carcinoma of the Renal Pelvicalyceal System Undergoing Radical Nephroureterectomy: A Propensity Score-weighted Analysis After Central Pathology ReviewThomas Seisen, Andrea Mari, Riccardo Campi, et al.
BJU International|October 16, 2015
The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette-GuérinPaolo Gontero, Richard Sylvester, Francesca Pisano, et al.
Annals of Surgical Oncology|June 8, 2011
Oncologic outcomes and survival in pT0 tumors after radical cystectomy in patients without neoadjuvant chemotherapy: results from a large multicentre collaborative studyMorgan Rouprêt, Sarah J Drouin, Stéphane Larré, et al.
European Urology|July 22, 2014
Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patientsPaolo Gontero, Richard Sylvester, Francesca Pisano, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Urologic Oncology|February 14, 2013
Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinomaGéraldine Pignot, Pierre Colin, Marc Zerbib, et al.
World Journal of Urology|July 2, 2013
Risk stratification of metastatic recurrence in invasive upper urinary tract carcinoma after radical nephroureterectomy without lymphadenectomyPierre Colin, Tarek P Ghoneim, Laurent Nison, et al.
Annals of Surgical Oncology|July 31, 2012
Influence of positive surgical margin status after radical nephroureterectomy on upper urinary tract urothelial carcinoma survivalPierre Colin, Adil Ouzzane, David R Yates, et al.
European Urology|September 25, 2018
Mutational Profile of Aggressive, Localised Prostate Cancer from African Caribbean Men Versus European Ancestry MenLaurie Tonon, Gaëlle Fromont, Sandrine Boyault, et al.
Urologic Oncology|September 19, 2016
The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non-muscle-invasive bladder cancerJ Alfred Witjes, Guido Dalbagni, Robert J Karnes, et al.
BJU International|July 9, 2020
Urology surgical activity and COVID-19: risk assessment at the epidemic peak: a Parisian multicentre experienceAlexandre Ingels, Steeven Bibas, Maher Abdessater, et al.
European Urology Focus|January 19, 2021
Prognostic Impact of pT3 Subclassification in a Multicentre Cohort of Patients with Urothelial Carcinoma of the Renal Pelvicalyceal System Undergoing Radical Nephroureterectomy: A Propensity Score-weighted Analysis After Central Pathology ReviewThomas Seisen, Andrea Mari, Riccardo Campi, et al.
BJU International|October 16, 2015
The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette-GuérinPaolo Gontero, Richard Sylvester, Francesca Pisano, et al.
Annals of Surgical Oncology|June 8, 2011
Oncologic outcomes and survival in pT0 tumors after radical cystectomy in patients without neoadjuvant chemotherapy: results from a large multicentre collaborative studyMorgan Rouprêt, Sarah J Drouin, Stéphane Larré, et al.
European Urology|July 22, 2014
Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patientsPaolo Gontero, Richard Sylvester, Francesca Pisano, et al.
Pageof 12